Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesity

Urology

Volumn 60, Issue 1, 2002, Pages 104-108

  Merrick, Gregory S ^a   Butler, Wayne M ^a   Wallner, Kent ^c   Galbreath, Robert W ^a,b,d   Anderson, Richard L ^a   Kurko, Brian S ^a   Lief, Jonathan H ^a,d  

^a WHEELING HOSPITAL   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d WHEELING JESUIT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; IODINE 125; PALLADIUM 103; PROSTATE SPECIFIC ANTIGEN; SILDENAFIL;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLADDER CATHETERIZATION; BLOOD LEVEL; BODY MASS; BRACHYTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOSIMETRY; DRUG EFFICACY; ENTEROPATHY; ERECTILE DYSFUNCTION; EVALUATION; FOLLOW UP; HUMAN; IMPLANT; INTESTINE FUNCTION; MALE; MORBIDITY; OBESITY; PENIS ERECTION; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RECTUM; RECTUM FISTULA; RECTUM ULCER; SCORING SYSTEM; SEXUAL FUNCTION; SYMPTOM; TRANSURETHRAL RESECTION; URETHRA STRICTURE; URINARY DYSFUNCTION; URINE INCONTINENCE;

ADENOCARCINOMA; AGED; BRACHYTHERAPY; HEALTH STATUS; HUMANS; IMPOTENCE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; OBESITY; PALLADIUM; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOISOTOPES; RADIOMETRY; TREATMENT OUTCOME; UROLOGIC DISEASES;

EID: 0036298352     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01638-2     Document Type: Article

References (20)

1. The risks of surgery in obese patients
2. Guidelines for healthy weight
3. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults
4. The effect of age on the association between body-mass index and mortality
5. Prostate brachytherapy in obese patients
6. Pelvic irradiation of the obese patient: A treatment strategy involving megavoltage simulation and intratreatment setup corrections
7. Potential role of various dosimetric quality indicators in prostate brachytherapy
8. The effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation
9. Modified uniform seed loading for prostate brachytherapy: Rationale, design, and evaluation
10. Seed fixity in the prostate/periprostatic region following brachytherapy
11. Extracapsular radiation dose distribution following permanent prostate brachytherapy
12. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43
13. Temporal resolution of urinary morbidity following prostate brachytherapy
14. Rectal function following prostate brachytherapy
15. Erectile function after permanent prostate brachytherapy
16. Consensus statement: Guidelines for PSA following radiation therapy
17. The dosimetry of prostate brachytherapy-induced urethral strictures
18. Pathophysiology and diagnosis of male erectile dysfunction
19. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer